ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000253.1|Oviedomycin_1 # 2 # 1219 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0000253.1|Oviedomycin_1 	2	1219	+	Loose	575	26.5646	EAM-1	32.81	3006873	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EAM beta-lactamase	GATCCGGCTTTCGAGGGGCCGTACTTCCAGTCGCACAACGCCGGCCGGCACCGGGAGGCGGCCGAGGGGCTGTTCGCGGCGGGGCGGGCGTACTACTGCGACTGCACCCGGGAGCAGCTGAAGGAGCGCACGGGGTCGGAGCACCTGGGGTACGACGGGTTCTGCCGGGAGCGGGGGCTCGGGTACGCGGCCGGGCGGGCGCTGCGGTTCCGGACGCCGGACGAGGGGGAGACCGTCGTCGCCGACCTGGTGCGCGGCGAGCCGGCGTTCCCGAACAGCGCGATCGAGGACTTCGTGATCGCCCGCGGTGACGGCTCTCCGGTCTTCCTGCTCGCCAACGTCGTGGACGACCTGGACGAGGGCATCACGCAGGTCATCCGGGGCGAGGAGCATCTGTCGAACACACCGAAGCAGCAGCTGCTGTGGGAGGCGCTCGGTGCCGGGCCGCCGGTGTGGGCGCATCTGCCGGTCATCGTGAACGAGAAGCGGCAGAAGCTGTCCAAGCGCCGGGACAAGGTCGCGCTGGAGGACTACCTCGGCGAGGGCTTCCTGCCCGAGGCGCTGGTGAACTACCTGATGCTGCTCGGCTGGGGCCCGGGCGGCGACCGGGAGATCATGCCGTACGAGGAGCTGGAGCGGCTCTTCCGGATCGAGGACGTCAACACCGCCCCGGCCTTCTTCGACGTGAAGAAGCTGACGGCCTTCAACGGCGAGTACCTCCGCGCCCTGGCGCCCGCGCAGTTCGCCGCGGCCTGTGTGCCGTGGCTCGTCGCGCCGTACGCCCCGTGGCGGCCGGAGGCGTTCGACAAGGACGTCTTCGAGGCGGCGGCTCCGCTGGCCCGGACCCGGTTGACGCGGCTCTCCGAGATCACCGGCTACGTGGACTTCCTGTTCCTCGATGAGCCGGTGGACGACGAGGTGTCGTGGCACAAGGCGATGAAGGAGGGGGCCGCGGACATCCTCACGGACGTCCGCGCCGGACTGGCCGCCGTCACCGGCTGGACGGCGGAGGAGCTGAAGGGCGTCCTGCTCGCCGTGGGGGAGCAGCACGGGCTGAAGCTGGGCAAGGCCCAGGCCCCGGTCCGGGTCGCGGTCACCGGGCGCACGGTCGGGCTCCCGCTGTTTCGAGTCCCTGGAACTGGCTCGGCCGGGAGCGGGTGCTGGCCCGGCTGGACACCGCAGATCCGGAGACTGGCGGGGCGGGGCGCGCCGGGGTAG	DPAFEGPYFQSHNAGRHREAAEGLFAAGRAYYCDCTREQLKERTGSEHLGYDGFCRERGLGYAAGRALRFRTPDEGETVVADLVRGEPAFPNSAIEDFVIARGDGSPVFLLANVVDDLDEGITQVIRGEEHLSNTPKQQLLWEALGAGPPVWAHLPVIVNEKRQKLSKRRDKVALEDYLGEGFLPEALVNYLMLLGWGPGGDREIMPYEELERLFRIEDVNTAPAFFDVKKLTAFNGEYLRALAPAQFAAACVPWLVAPYAPWRPEAFDKDVFEAAAPLARTRLTRLSEITGYVDFLFLDEPVDDEVSWHKAMKEGAADILTDVRAGLAAVTGWTAEELKGVLLAVGEQHGLKLGKAQAPVRVAVTGRTVGLPLFRVPGTGSAGSGCWPGWTPQIRRLAGRGAPG	MSVKALFAALPLLIAACAAIPAPQVEDADAPPSPAPTETVVNAHEMQMAFLDACEPWDEWDKPAPPFQLMGNSWYVGTCGISAVLITGEDGHILIDSGVPEAAPLVLANIASLGFDAKDVRYLLMSHEHFDHVGAHAAIKEATGAQVLASVRAKPVLETGKVAADDPQAASGHPDMTPVKVDRVIGDGEILDLGNLRVTAHETPGHSPGALSWTWWSCSLPGEPPVCNRFAYVDSLSAVSADDYRFTDHPEMVRAFRTSIDKARMLQCEFLVTPHPSAGSMLDLMSGEHGLYLHKGCGFYAKRLSKRLDERLAKEAAE	127.36	gnl|BL_ORD_ID|3516|hsp_num:0	4585			303	495	
BGC0000253.1|Oviedomycin_3 # 1862 # 2224 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0000253.1|Oviedomycin_3 	1862	2224	-	Loose	400	25.0238	ErmB	26.67	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCGAACGACGGAGGAGACCCGGCTGCCGCAGCCGGACCTCGCCACGGTGGAGATCGGCACCGTGCTGCAAGCCCTCGCGGACCCGGTACGGCTGCAGATCGTGCGGTTGCTCGACACCGTCGGCGAGGCGCCCTGCGGCGCGCTGGAGCTTCCGGTCGGGCGCTCCACCGTCTCCCACCACCTGCGCACCCTGCGCGAGAGCGGCCTCGTCGAGACGCATCTGCGGGGCAACACCCGGGTCAGCCGGATCCGCCGCGAGGAGCTGGAACGGCGCTTCCCCGGACTGCTCGCCTCCGTCCTGGGTGCCACGCCGGCCGCGCAAGCGGGCACGGCCGCGAGCGACGAGGAGGGGGAACGCTAG	MRTTEETRLPQPDLATVEIGTVLQALADPVRLQIVRLLDTVGEAPCGALELPVGRSTVSHHLRTLRESGLVETHLRGNTRVSRIRREELERRFPGLLASVLGATPAAQAGTAASDEEGER	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	48.39	gnl|BL_ORD_ID|1424|hsp_num:0	1549			39	309	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000253.1|Oviedomycin_4 # 2296 # 3627 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.742	BGC0000253.1|Oviedomycin_4 	2296	3627	+	Loose	700	142.895	cmx	36.81	3002703	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGATGTCGCTCGACATCTACGATACACATCGAACCTCTATTACGATCGACATCGACATACCCGACGTCCATCGAAACTCAGGTGCTTCCATGACCCCTCCCGCCGCACAGCAGGGGCGCGCCTGGCGGACCCACGCCTGTGTGCTCGCACTCGGCACGTTCGCCGTCGGCACCGACGCCTTCGTCATCGCCGGCCTGCTCCCCGACATCAGTGACTCGCTCGACATCTCCGTGGGCGCGGCGGGCCAGCTCGTCAGCGTCTTCTCGCTGGCCTACGCCCTGCTCTCCCCGGTGCTCGCCGCGTTCACCGCCCGCTGGTCACGCCGTACGGTGCTGATCACGGGGCTCGGCGTGTTCGCCGTCGGCAACGTGGTCACCGCCCTCGCCCCCGACTACGCGCTCGTCCTGGCGGCCCGGGTGATCGCCGCGGCCGGCGCCGCGATGTTCACCCCCAACGCGGGCGCGACCGCGGCGACCCTGGCCGGACCCGAGCACCGGGGCCGGGCGATCGCCATCGTCACCGTGGGGCTGACCGCCTCGCTCGCGCTGGGCGCGCCGCTCGGCACCGTCATCGGCGAGGCGCTGGGCTGGCAGGCCACCATGTGGTTCGTCACCGCGCTCGCCCTGGTCGTGGCCCCGGTCATCGCCCTGCGGCTGCCCGACGTCACCCTGGGCGGCCCGACCCAGCTGCGGCGGCGCCTCGCCCCGCTCGCCGACCGCAAGGTCGCCGGGGTACTGGCCGGCACGCTGGTCGCGTTCATCGGCATCTACCTGCCCTACACCTACATCAGCGCCGTCTTCGAGCCCGCCACCGGCGGGGACGGTGACAAGGTGGCCGTACTGCTGCTGGTCTTCGGCCTGGCGGGGACGGCCGGCAACCTCACCGCGGGCCGGCTCGCCGACCGCAAGGGGCCGCGCACGGTCGTCATCGGCGCGACGCTGCTGCTGACGGTGGTGTTCGCGGTCATGGCCGGCGTCCGCTCCTCCTACCCGGCCGCCGTCGCGCTGACGGCGGTGTGCGGCGTCGCCTCCTGGTCGGTGACCGCGCCGCAGCAGCAGCGCGTCATGGCGCTGGCCAGCCCCGGCAGCGAGCCCCTGGCCGTCTCCCTCAACGCCGCCGTGATGTACCTGGCGATCTCGCTGTCCAGCGCGCTGGGCGCCGGGATCCTCGGTGCGACGGGTGCCGTGTGGATCGCCTGGGCGGGCGCCGCCTTCGCCGTGGCCGCGGCGCTGGTCACGGCCGCCGCCGCCCGCACCGAGCGGGCCGGCGCCGGGTCCGCGGAGCCGGAGCGGGAGCCGGCCGGGGCGCAGGAGGCGTCCGCCGGTTAG	MAMSLDIYDTHRTSITIDIDIPDVHRNSGASMTPPAAQQGRAWRTHACVLALGTFAVGTDAFVIAGLLPDISDSLDISVGAAGQLVSVFSLAYALLSPVLAAFTARWSRRTVLITGLGVFAVGNVVTALAPDYALVLAARVIAAAGAAMFTPNAGATAATLAGPEHRGRAIAIVTVGLTASLALGAPLGTVIGEALGWQATMWFVTALALVVAPVIALRLPDVTLGGPTQLRRRLAPLADRKVAGVLAGTLVAFIGIYLPYTYISAVFEPATGGDGDKVAVLLLVFGLAGTAGNLTAGRLADRKGPRTVVIGATLLLTVVFAVMAGVRSSYPAAVALTAVCGVASWSVTAPQQQRVMALASPGSEPLAVSLNAAVMYLAISLSSALGAGILGATGAVWIAWAGAAFAVAAALVTAAAARTERAGAGSAEPEREPAGAQEASAG	MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN	113.30	gnl|BL_ORD_ID|1252|hsp_num:0	1366			18	969	chloramphenicol
BGC0000253.1|Oviedomycin_5 # 3855 # 4688 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.741	BGC0000253.1|Oviedomycin_5 	3855	4688	+	Loose	634	25.7942	BRO-2	21.33	3004762	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BRO Beta-lactamase	ATGATCCTGGTGACCGGTGCGACCGGCAACGTCGGCCGGAACCTGGTGCGCGAACTGCTGGAAGCGGGAGCGCGGGTACGCGCGCTCACCCGTGACCCGCGCCGCGCCGGCCTGCCGGACGGAGTCGACGTGGCCCAGGGAGACCTGACCGATGCCGAGTCCCTCGCCTCCGCGCTGCGCGGCGTGGAGCGGGCGTTCCTCTTCCCCGTGCACGGCCGGCTGGGCGCGTTCCTGGACGCCGCGACGCGGGCGGGGCTGAAGCAGGTGGTGCTGCTGTCCTCGCAGTCGGTGGTGGACGAACACCTGAGCCGGGAGCGGATGGGCAGGCTCAACGCGGCCGACGAGCAGGCCGTCATCGCCTCCGGTGTGCCGTGGACGTTCCTGCGCCCCGGCCCGTTCATGGTCAACGACCTGCCGTGGGCGTGGGGCGTCAAGGCGGAGGGCGTGGTCCGCGCGGCATACGGCGACGCCGCCACCGCGCCCGTCGACGAGCGGGACATCGCCGCCGTGGCCGCCCGCGCCCTGCTGGACGACGACCACGTGGGACGGGCCTACGAGCTGACCGGCCCCCAGTCGCTGACCCAGGCCGAGCGCGTACGCATCCTCGGCGAGGTGCTCGGCAGGGAACTGCGCTTCGAGGAACTGTCGCCCGAGGCGGCCCGGGAGCGGATGACCCGGCACCTGGAGGCGGAGACGGTCGACTCCCTGCTGCGCATGTTCGCCCGCCAGTCCGGCACGACGGTGCCGGTGTCCACGGCGGTGCGGGACGTCACCGGCCGCCCGGCGCACACCTACGCCGAGTGGGCGGCCCACCACGCCGGTGACTTCAGGTGA	MILVTGATGNVGRNLVRELLEAGARVRALTRDPRRAGLPDGVDVAQGDLTDAESLASALRGVERAFLFPVHGRLGAFLDAATRAGLKQVVLLSSQSVVDEHLSRERMGRLNAADEQAVIASGVPWTFLRPGPFMVNDLPWAWGVKAEGVVRAAYGDAATAPVDERDIAAVAARALLDDDHVGRAYELTGPQSLTQAERVRILGEVLGRELRFEELSPEAARERMTRHLEAETVDSLLRMFARQSGTTVPVSTAVRDVTGRPAHTYAEWAAHHAGDFR	MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLGFKNQKDEIMAQIGKEIYPFL	88.22	gnl|BL_ORD_ID|2406|hsp_num:0	3566			540	738	
BGC0000253.1|Oviedomycin_6 # 4685 # 5332 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000253.1|Oviedomycin_6 	4685	5332	+	Loose	400	50.8322	MexL	48.08	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGGAAGCCGTACGCAGGCGGGCGCGGAACCGGAGCGCAAGGGCGAGCGCACCCGCCGGCGGATCATGGAGGCCGCGCGCCGCAAGTTCGCCGAGGTCGGCTACGAACGCGCCACGATCCGGGCCATCGCCGCCGAGGCGGGAGTCGACAAGGCGTCCGTCATCCAGTACTTCGGCACCAAGCAGGAACTCTTCCGCGAGGCGGTCCGCTGGCACGTCCCGATCGAGGAGCTGACGACCCCGGACCCGGCGCGCACGGTCGACAACTACCTCCGCGCCATGCTGAGCAGCTGGGCGGCCGACCCGGACAGCCCCATGGCGGTGCTGCTGCGCACCAGCATGACCAGCGAGGAGGCCGCGGAGCTGCTGCGCCGGCATGTGACCAAGGAGACCGTCGAGCGGGTGGCGGCGAACGTCGACGCCCCGGACGCGCGGCTGCGCGCCGCGCTGTCCGGGGCGATGATGTTCGGCATCGCGACCCAGCGGTACCTGCTGCGCATGCCCGACCTGGCCGAGGCCGACCTGGACGACGTACTGCGCCTGGCGGCACCGCTGTTCCGCACCCTGATCGCCCCCGGCTCGGAGCCGGGGACGGAGCCGGGGGCGGCACCCGGGACGGATCCGGAGACGGTGCCCGGGTCCTGA	MTGSRTQAGAEPERKGERTRRRIMEAARRKFAEVGYERATIRAIAAEAGVDKASVIQYFGTKQELFREAVRWHVPIEELTTPDPARTVDNYLRAMLSSWAADPDSPMAVLLRTSMTSEEAAELLRRHVTKETVERVAANVDAPDARLRAALSGAMMFGIATQRYLLRMPDLAEADLDDVLRLAAPLFRTLIAPGSEPGTEPGAAPGTDPETVPGS	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	101.42	gnl|BL_ORD_ID|4690|hsp_num:0	2219			54	210	erythromycin; tetracycline; triclosan
BGC0000253.1|Oviedomycin_7 # 5346 # 5537 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.729	BGC0000253.1|Oviedomycin_7 	5346	5537	-	Loose	500	22.3274	APH(3')-Ib	22.58	3002642	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAGCCGTACGCCACGGCGGCGCTTCGTGCCCACGGAACTCGCCGCGCTCGCGGCCGGGGTGACGGAGGCCACCATCCGCAAGTGGGCCAGCCGCGGCAAGATCACCCGCTACGGCAGCCCCCGGCGCGCCCAGTACGACCTGGACGAACTCATCGCCATCGTCGCCGACCGGTCCGAGGCCCTCGGCTGA	MSRTPRRRFVPTELAALAAGVTEATIRKWASRGKITRYGSPRRAQYDLDELIAIVADRSEALG	MNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDAFADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVVVDALAAFMRRLHAIPVSECSVQQWTTHAGLPERGSIEAGVVDVDDFDKEREGWTAEQVWEAMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFEPSLQERLVAQYGIADPDRRKLQFHLLLDELF	23.25	gnl|BL_ORD_ID|772|hsp_num:0	835			405	498	neomycin; ribostamycin; kanamycin A; gentamicin B; paromomycin; lividomycin; gentamicin
BGC0000253.1|Oviedomycin_8 # 5534 # 6187 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000253.1|Oviedomycin_8 	5534	6187	-	Loose	700	25.409	vanS gene in vanB cluster	35.14	3002932	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGCGCCAAGTTCTGCAATTGTCAGAAACGTCGGAGGAGAAACCCAGCGCGGACGCGCTGATCCCAACTCTGCGTACCCTCGCGGAGCTTTACGAGGAATGCGGGCGGATGTTAGCGCATACTCCGCACAGCCTGCGCCAGCGTGTCACCGGAAGCCGCGCCACCGGAATTTCTCTCAACGAGAAGGCCATGGCGATACGGACGGAGACCCAGAACACGCTCGGTTCCTGGGCGCGCCTGGTGGTGGACGAGTGCGGCACGGCCGGTCCGTCCCGGGAGGGGATTCCTCCCCTGGTGTCCTTCCTCATCCGCCATTCCGGATGGCTGGCCGCGCATCCGGCGGCCGGTGACTTCGCCGAGGAGATCGCCGCGCTCGTGAGGTCCGCCCGCCGTATCGCGGGCCCCGGCCCCGCCCACCGCGTCGACCTGGGGCGCTGCCTGCGGTCCGGCTGTGCGGGCACGCTGCGTGCCGTGGTGCACGACGGGGACGACGCGACACCGGGGCAGGTGGCGTGCGACGCCGGGCACGCGCTGCCGCCGCAGCAGTGGCTGCTGGTCGCGCACCGCATGCGGCGGACCGCCTCGCGCGGCGAGCGCGTCACCCGGCGCCACGACGGTGACCGGGCCGGTGTCCGCGAGGAGGCCGCCCGATGA	MRQVLQLSETSEEKPSADALIPTLRTLAELYEECGRMLAHTPHSLRQRVTGSRATGISLNEKAMAIRTETQNTLGSWARLVVDECGTAGPSREGIPPLVSFLIRHSGWLAAHPAAGDFAEEIAALVRSARRIAGPGPAHRVDLGRCLRSGCAGTLRAVVHDGDDATPGQVACDAGHALPPQQWLLVAHRMRRTASRGERVTRRHDGDRAGVREEAAR	MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSDRLDMQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVAQSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKEVPPPLERKDELGALAHDMHSMYIRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIAAVSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPKLIQKALSNVILNAVQNTPQGGEVRIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLDAMSLQYALENTSDGVLFWLDLPPTSTL	48.55	gnl|BL_ORD_ID|4672|hsp_num:0	499			1176	1287	vancomycin
BGC0000253.1|Oviedomycin_9 # 6337 # 6633 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.576	BGC0000253.1|Oviedomycin_9 	6337	6633	+	Loose	850	27.335	OpmB	50.0	3004072	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTTTCGAGAGTGCCGGACACGTGCGGTGAAATTGCGGTTTATCAGTGTGTACTGCCCCCGTGCAACGCGAATGAATTCTGGCCTGTGGGCCCCCGGCTCGCAGTCACAGTCTGCGTAGGCGGCGAAGGCTTCGTCAAGCAAAGAAAGGGGAAAGTGGAAGTCGGCGATCATTTCTCGCGGGGCGGGAAAACGGGGGATGGATGTCCGGGGTTGCGCCTTACGTCCCATGTATGTGACGGCGATTTCCCTGGAAGGCTTCACCTTTTTGCGTCGTATGTCCGCAGATGTCCGTAA	MVSRVPDTCGEIAVYQCVLPPCNANEFWPVGPRLAVTVCVGGEGFVKQRKGKVEVGDHFSRGGKTGDGCPGLRLTSHVCDGDFPGRLHLFASYVRRCP	MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP	19.68	gnl|BL_ORD_ID|2312|hsp_num:0	2716			1035	1089	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000253.1|Oviedomycin_10 # 6721 # 7527 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.739	BGC0000253.1|Oviedomycin_10 	6721	7527	+	Loose	1800	29.6462	mdtC	27.96	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGGGATCGTGCGTGGTGGAGAGACGGGGGTCGCCATGGACATGCACGCGGTTTCGGCCGACGGACGGACCGGCGAGCGCGTCCGTGCGGGCGGCACCACGCACGCGGAGCGCGTGTTCCGGGTCCAGCAGGCGTTCCTCAAGCTGCGCGGCCGGACGCACGGCCCCGGAGAGCTGGCCGAGGCGGCCGGACTCGACGACTCCGCCGTCCACCGCATCCTGCAATCCGGCATCTACGAGGGCGTCTTCGACCGCGTCGGCCGCGGCATGTACCAACTCGGCACCACGGCGGCCCTGGTGGGCATGCAGGCCATGGCGCACACCCTCGACCGCCACACCGCCCGGTCGATCCTGCTCAGGCTGCGCGCCGCCACCGGGGGCGGGCTCGCCTTCCTCTACACGCTCGCCCCGTTCGGCGGCGCCCAGCGGCAGTGTGTCGACATGGCCGTCGGCGACTCCGACCTCTCCGAACTCGGCATGACACCCCGCGAGGTGCTGACCGTCACCCGCTCGCTGCGCGTCGGCGCGTCCGGCCGCGCCATCCTCGCCTACCTCCCGCGCCCCCTCCAGGAACGGGTGGCCGCCGAGCCCGCCGTGACCGAGGCGGGCCCCGGCGTGCTGGTGGACGACGACGCGCTGTGGGACTCACTGCGCGACATACGCGACCAGGGCTACGCCATCGGCCTGGAGGAGTGCATCGCCGGCTGGAACTCCTGCGCCGCCCCCGTGATGTGGGGACGGCTGGGGTCTTCGGCGCGGTCCTCGTGCTCCTGCCGGACTCCGAGCCCGTCCGCCCGGACGTGA	MAGIVRGGETGVAMDMHAVSADGRTGERVRAGGTTHAERVFRVQQAFLKLRGRTHGPGELAEAAGLDDSAVHRILQSGIYEGVFDRVGRGMYQLGTTAALVGMQAMAHTLDRHTARSILLRLRAATGGGLAFLYTLAPFGGAQRQCVDMAVGDSDLSELGMTPREVLTVTRSLRVGASGRAILAYLPRPLQERVAAEPAVTEAGPGVLVDDDALWDSLRDIRDQGYAIGLEECIAGWNSCAAPVMWGRLGSSARSSCSCRTPSPSART	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	26.15	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2169	2430	novobiocin
BGC0000253.1|Oviedomycin_11 # 7963 # 9447 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.744	BGC0000253.1|Oviedomycin_11 	7963	9447	+	Loose	600	328.561	Streptomyces venezuelae rox	44.72	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGACGCTGCCCTCGTCGACGTTCCCGTGGTCATCGTGGGAGCAGGCCCCACGGGGCTGATGCTCGCCGGTGAACTGCGCCTCGCCGGAGTCGAGATCGTCGTCATCGACCGCCTTCCCCGGCCCAGCGGAGAGTCCCGCGGGCTCGGTTTCACCCCTCGCACCATGGAGGTCTTCGACCAGCGCGGACTGCTGCCCCGCTTCGGCGAGATCGTCACCAGCAAGCTCGGCCACTTCGGCGGCACCCCCGTCGACTTCGGCGTGCTCGACGGCGCCCACTTCAGCGTCAAGGACGTGCCCCAGCACCGTACGGAGGCGGTGCTCGGCGCATGGCTCGCCGAACTCGGCGTCCAGGTGCGGCGCGGCCGCGAACTCGTCGCCCTCACGGCCGGCGAGGACGGCGTCCGCATCGACATCGAGGGCCCCGACGGCCCCGAACGGCTGCGCGCCGGCTACCTGGTGGGCTGCGACGGCGGCCGCAGCACGGTCCGCAGACTCGCCGGGTTCGACTTCCCCGGCACCGCCGCGACCATGGAGATGTACCTCGCCGACATCACCGACTGCGAGGTGCGGCCCCGCCCCATCGGCGAGTCCGTGCCCGGCGGGATGGCCATGTCGGTGCCCATCGGCGACGGCGTCCACCGCATCATCGCGTGCGAGCGCGACAACCCCCCGCGCGAACGCACCGGACCGCCGCCCTTCGCGGAGGTCGCCGCCGCCTGGCAGCGCCTGACCCACCAGGACACAGCGGCGCCACCCGGTGTGGGTCAGCGCTTCGGCAACGCCGCCCGCCAGGTCACCGAGTACCGCCGCGGACGCGTCCTGCTGGCCGGCGACGCGGCGCACATCCACCTGCCCGCCGGCGGCCAGGGCATGAACACCGGCATCCAGGACGCCGTCAACCTGGGCTGGAAGCTCGCCGCCGTCGTACGCGGCACGGCCCCCGAGGCGCTGCTCGACACCTACCACGCCGAGCGCCACCCGGTCGGCCGCCGGCTGCTGACCAACACGCAGGCCCAGGGCCTGCTCTACCTCAGCGGCAGCGAGATGCAGCCGCTGCGCGACGTGCTCGCCGAGCTGATCGCGTACGAGGACGTCAGCCGCCACCTCGCCGGAATGATCAGCGGCCTGGACATCCGCTACGACGTCGGCGCGACCGATCACCCGCTGCCCGGCCGCCGCATGCCGCACCTGGAACTCGTGACCGCCGACGGCGGCAAGACCAGCACCACCGCCCTGCTGCACAGCGCGCGCGGCTTGCTGCTCGACCTCGCCGACGACCCCGGGACCCGGCGCGCCGCCGCCGGCTGGGCGGACCGCGTGGACACCGTCACCGCGACCCCGCACGACACCGCCCAGGACCGGCCGCCGCACGGCGCCACCGCCGTACTGGTGCGCCCCGACGGCCATGTGGCCTGGGCCGCGCCCGGCGGTCCCGGGGAGCTGACCGCCGCCCTGGAGCGCTGGTTCGGCCCGTCCCGCTGA	MDAALVDVPVVIVGAGPTGLMLAGELRLAGVEIVVIDRLPRPSGESRGLGFTPRTMEVFDQRGLLPRFGEIVTSKLGHFGGTPVDFGVLDGAHFSVKDVPQHRTEAVLGAWLAELGVQVRRGRELVALTAGEDGVRIDIEGPDGPERLRAGYLVGCDGGRSTVRRLAGFDFPGTAATMEMYLADITDCEVRPRPIGESVPGGMAMSVPIGDGVHRIIACERDNPPRERTGPPPFAEVAAAWQRLTHQDTAAPPGVGQRFGNAARQVTEYRRGRVLLAGDAAHIHLPAGGQGMNTGIQDAVNLGWKLAAVVRGTAPEALLDTYHAERHPVGRRLLTNTQAQGLLYLSGSEMQPLRDVLAELIAYEDVSRHLAGMISGLDIRYDVGATDHPLPGRRMPHLELVTADGGKTSTTALLHSARGLLLDLADDPGTRRAAAGWADRVDTVTATPHDTAQDRPPHGATAVLVRPDGHVAWAAPGGPGELTAALERWFGPSR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.78	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1419	rifampin; rifaximin; rifapentine
BGC0000253.1|Oviedomycin_12 # 9556 # 9888 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.664	BGC0000253.1|Oviedomycin_12 	9556	9888	+	Loose	700	23.0978	OCH-3	26.23	3002516	protein homolog model	n/a	n/a	monobactam; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	OCH beta-lactamase	ATGAAGCACAGCACGTTGATCGTGGCCCGGATGGAGCCGCACGCCAGTGACGACGTCGCGGCCCTCTTCGGCGCCTTCGACAGGACCGAGATGCCCCACCGCATGGGCACCCGCCGCCGTCAGCTGTTCAAGTACCGGGGCCTGTACTTCCACCTCCAGGACTTCGACACCGACAACGGCGGCGAGCTGATCGAGGAGGCCAAGACCGACCCGCGCTTCATCCGGATCAGCGAGGACCTCAAGCCGTTCATCGAGGCGTACGACCCGCAGACGTGGCGCTCGCCCAAGGACGCGATGGCCACGCGCTTCTACCACTGGGAGGCCTCCGCATGA	MKHSTLIVARMEPHASDDVAALFGAFDRTEMPHRMGTRRRQLFKYRGLYFHLQDFDTDNGGELIEEAKTDPRFIRISEDLKPFIEAYDPQTWRSPKDAMATRFYHWEASA	MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITIDGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFTLSDPATKWAPELADSSFDKITMLDLGTYTPGGLPLQFPDAVSDDSSMLAYFKKWKPDYPAGTQRRYSNPSIGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSGGALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYRVDANNQGLGWEFYNYPTALKTLLEGNSSDMALKSHKIEKFDTPSQPSADVWLNKTGSTNGFGAYAAFIPAKKIGIVLLANRNYPIDERVKAAYRILQALDNKQ	28.21	gnl|BL_ORD_ID|183|hsp_num:0	201			441	624	
BGC0000253.1|Oviedomycin_13 # 9885 # 11009 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.715	BGC0000253.1|Oviedomycin_13 	9885	11009	+	Loose	700	25.7942	gimA	31.82	3000463	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	gimA family macrolide glycosyltransferase	ATGACGCCCCGGCGCGTCGTCATCACCGGCATCGGCGTGCTCGCGCCGGGCGGCATCGGTGTGAAGAACTTCTGGAGCCTGCTGAGCGAGGGCCGCACCGCGACCCGCGGCATCACCTTCTTCGACCCCGCCCAGTTCCGCTCGCGGGTCGCCGCCGAGATCGACTTCGATCCGGAGGAACACGGGCTGAACCCGCAGGAGACACGGCGCATGGACCGCGCCGCCCAGCTCGCCGTCGTGGCCACCCGCGAGGCGGTCGCCGACAGCGGCATCGAGCTGACCGGCATCGACCCGTACCGCGTCGGCGTCACCGTGGGCAGCGCGGTCGGCGCGACCATGGGGCTGGACCAGGAGTACCGGGTCGTCAGCAACGGCGGCCTGCTCGACCTGGTCGACCACACGTACGCGGTCCCGCACCTGTACAACCACATGGTCCCCAGCTCCTTCGCCGCCGAGGTCGCCTGGCAGGTGGGCGCGGAGGGCCCCAGCACGGTGGTCTCCACCGGCTGCACCTCCGGCCTGGACTCGGTCGGCCACGCGGTGGAGCTGATCCGCGAGGGCTCGGCGGACGTCATGATCGCCGGCTCGTCGGACGCGCCGATCTCGCCTATCACCATGGCGTGCTTCGACGCGATCAAGGCGACGACCCCGCGCAACGACGACCCCGAGCACGCCTCCCGCCCCTTCGACGGCACCCGCAACGGCTTCGTGCTCGGCGAGGGCTCCGCCTTCTTCGTACTGGAGGAGCTGGAGAGCGCCCGCGCGCGCGGCGCCCACGTCTACGCCGAGATCGCCGGCTACGCCACCCGCTCCAACGCGTACCACATGACCGGGCTGCGCCCCGACGGCGCCGAGATGGCCGAGGCCATCCGCGTCGCGCTCGACGAGGCCCGGATCAACGGCGACGAGATCGACTACATCAACGCGCACGGCTCCGGCACCAAGCAGAACGACCGGCACGAGACGGCCGCGTTCAAGAAGAGCCTCGGCGACCACGCGTACCGCACCCCGGTCTCCTCCATCAAGTCGATGGTGGGCCACTCGCTGGGCGCGATCGGCTCCATCGAGATCGCCGCGTCCGCCCTGGCCATGGTGCTCGCCCGGCCCGAGAGGAGCGTGGCATGA	MTPRRVVITGIGVLAPGGIGVKNFWSLLSEGRTATRGITFFDPAQFRSRVAAEIDFDPEEHGLNPQETRRMDRAAQLAVVATREAVADSGIELTGIDPYRVGVTVGSAVGATMGLDQEYRVVSNGGLLDLVDHTYAVPHLYNHMVPSSFAAEVAWQVGAEGPSTVVSTGCTSGLDSVGHAVELIREGSADVMIAGSSDAPISPITMACFDAIKATTPRNDDPEHASRPFDGTRNGFVLGEGSAFFVLEELESARARGAHVYAEIAGYATRSNAYHMTGLRPDGAEMAEAIRVALDEARINGDEIDYINAHGSGTKQNDRHETAAFKKSLGDHAYRTPVSSIKSMVGHSLGAIGSIEIAASALAMVLARPERSVA	MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLFAEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPDLVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARFRGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWRRPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVEVRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRHLPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART	89.69	gnl|BL_ORD_ID|1924|hsp_num:0	1994			156	288	tylosin; oleandomycin; chalcomycin; methymycin
BGC0000253.1|Oviedomycin_14 # 11006 # 12229 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.750	BGC0000253.1|Oviedomycin_14 	11006	12229	+	Loose	500	29.261	ESP-1	38.3	3003717	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ESP beta-lactamase	ATGACCGGCACGGCCACGAAGGTGGTGGTCACCGGACTGGGCGTCGCGGCCCCCAACGGCCTGGGCACCCAGGACTACTGGGCGGCGACCCGGACCGGCAAGGGCGGCATCGGCCGCATCACCCGCTTCGACCCCTCGCAGTACCCCTCCCGGCTGGCCGGCGAGGTCCCCGGCTTCGAGGCCCGCGACCACCTGCCCAGCCGGCTGCTGCCGCAGACCGACCACATGACGCGGCTCGCGCTCGTGGCCGCCGACTGGGCGCTCGCCGACGCCGGGGTCAAGCCGCAGGAGCTGCCCGAGTTCGACATGGGCGTGGTCACCGCCAGCTCCTCGGGCGGCTTCGAGTTCGGCCAGCGCGAACTCCAGGCGCTGTGGAGCAAGGGCGGCCAGCACGTCAGCGCCTACCAGTCCTTCGCCTGGTTCTACGCGGTCAACTCCGGCCAGATTTCGATTCGCAACGGCATGAAGGGGCCCAGCGGCGTCGTCGTCAGCGAGCAGGCGGGCGGCCTCGACGCGCTCGCCCAGGCCCGCCGGCAGATCCGCAAGGGCACCCGGCTGATCGTCTCCGGCGGCATGGACGCGTCCGTGTGCACCTGGGGGTGGGTCGCCCAGCTGGCCGGCAAGCGGCTGAGCACCAGCGACGACCCCGAGCGCGCCTACCTGCCGTTCGACGCCGGGGCGCGCGGGCACGTCCCGGGCGAGGGCGGCGCGATCCTCATCCTGGAGAACGCCGAGGCCGCCCGGTCCCGGGGCGCCCGGACCTACGGCGAGATCGCGGGCTACGGCTCCACGTTCGACCCCAAGCCGGGCAGCGGCCGCCCGCCGGGCCTGCGCAAGGCGATCGAGCTGGCCCTCGCGGACGCGGGCGCGGCCCCGGACGAGGTGGACGTGGTGTTCGCCGACGCCGCCGCCGTCCCGGAGCTGGACCGCATCGAGGCCGAGGCGCTCACCGCCGTCTTCGGCGCCCGCGGCGTCCCGGTCACCGCGCCCAAGACCATGACCGGCCGCCTGTACTCCGGCGCCGCCCCGCTGGACGTGGCCACCGCGCTGCTCGCCATCGAGGAGGGGCTGATCCCGCCCACCACGAACGTCGAGCCGGCCGACGGCTACGACCTGGACCTGGTCACCGGCGAGGCCCGCCCGGCCGAGGTGCGCACGGCGCTCGTGCTGGCCCGCGGCTTCAACGGGTTCAACTCCGCGCTCGTGGTCCGCGCCACCCACTGA	MTGTATKVVVTGLGVAAPNGLGTQDYWAATRTGKGGIGRITRFDPSQYPSRLAGEVPGFEARDHLPSRLLPQTDHMTRLALVAADWALADAGVKPQELPEFDMGVVTASSSGGFEFGQRELQALWSKGGQHVSAYQSFAWFYAVNSGQISIRNGMKGPSGVVVSEQAGGLDALAQARRQIRKGTRLIVSGGMDASVCTWGWVAQLAGKRLSTSDDPERAYLPFDAGARGHVPGEGGAILILENAEAARSRGARTYGEIAGYGSTFDPKPGSGRPPGLRKAIELALADAGAAPDEVDVVFADAAAVPELDRIEAEALTAVFGARGVPVTAPKTMTGRLYSGAAPLDVATALLAIEEGLIPPTTNVEPADGYDLDLVTGEARPAEVRTALVLARGFNGFNSALVVRATH	MKKLTLILSLIIAFFGYAQTVTEPTNHSAEWSQPYEPFRIVGNLYYVGTYDLASYLIVTEKGNILINTGLADSYPQIKANIEKLGFKYKDTKILTLTQAHFDHMGAMADIKAETGAKLYVDEADAAELKSGGKSDYELGKYGVTFKPLTPDFLLKNNGKIKLGNTTLTLLHHPGHTKGSCSFIFETKDENRKYKVVIANMPSIIIDHKFSDVKTYPSIQKDYAYTLEAMKKLDFDVWVASHASQFDLHKKRKEGDAYNPKLFMDKENYFKRLKDLEDDYLEKVKEENKPE	140.34	gnl|BL_ORD_ID|2029|hsp_num:0	2232			300	441	
BGC0000253.1|Oviedomycin_15 # 12310 # 12582 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.685	BGC0000253.1|Oviedomycin_15 	12310	12582	+	Loose	700	26.9498	LpsB	44.0	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGGCCACCAAGGAATTCACCGTCGACGACCTCAAGCGCATCCTCCTCGAAGGCGCCGGCGCCGACGAGAGCGTCGACCTCGACAGCGCCGACTTCCTCGACTCCGAGTTCGAGGCGCTGGGCTACGAGTCCCTGGCGCTGCTGGAGACCGGCGGCCGCATCGAGCGCGAGTTCGGCATCACGCTGGACGACACCGCGCTGACCGACGCCACCACCCCGCGTGCCCTCATCGAGGTCGTCAACGCGCACATCGGTCAGCCCACCGCGGTCTGA	MATKEFTVDDLKRILLEGAGADESVDLDSADFLDSEFEALGYESLALLETGGRIEREFGITLDDTALTDATTPRALIEVVNAHIGQPTAV	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	24.59	gnl|BL_ORD_ID|2781|hsp_num:0	3793			951	1026	colistin A; colistin B; defensin
BGC0000253.1|Oviedomycin_16 # 12706 # 13488 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.715	BGC0000253.1|Oviedomycin_16 	12706	13488	+	Loose	600	25.409	AER-1	27.78	3002481	protein homolog model	n/a	n/a	penam	antibiotic inactivation	AER beta-lactamase	ATGGCGCAGGACAAGCGGGTCGCCCTGGTGACCGGGGCGACCAGCGGCATCGGTCTGGCCGTGGCCCGGCTGCTGGCCGAGCAGGGGCACCGGGTGTTCCTGGGCGCGCGCAGCGCCGAGAACGTGGCCGCGACCGTGAAGGAACTGCAGAGCGCCGGCCTGGAGGCGGACGGCGCCACGCTGGACGTCCGCTCCGACGCCGACGTCCACGCCTTCGTGCGGGCGGCCGTGGACCGGTTCGGCACGGTGGACGTGCTGGTGAACAACGCCGGCCGCAGCGGTGGCGGAGTGACCGCGGACATCGCCGACGAGCTGTGGCACGACGTGATCGACACGAACCTCAACAGCGTGTTCCGGCTGACCCGCGAGGTGCTGAACACCGGTGGCCTCAGGCACAAGAGCTGGGGCCGGATCATCAACATCGCCTCCACCGCGGGCAAGCAGGGCGTCGTCCTGGGCGCCCCGTACTCGGCGTCCAAGCACGGCGTGGTCGGCTTCACCAAGGCCCTCGGCAACGAGCTGGCCCCGACCGGGATCACCGTCAACGCGGTCTGCCCGGGCTACGTCGAGACGCCGATGGCCCAGCGGGTGCGCCAGGGCTACGCCGCCGCCTACGACACCACCGAGGACGCGATCCTGGAGAAGTTCCAGTCCAAGATCCCGCTCGGCCGCTACTCCACCCCCGAGGAGGTCGCCGGGCTGGTCGGCTACCTGGCCTCCGACACCGCCGCCTCCATCACCGCCCAGGCGCTCAACGTCTGCGGCGGCCTCGGCAACTTCTGA	MAQDKRVALVTGATSGIGLAVARLLAEQGHRVFLGARSAENVAATVKELQSAGLEADGATLDVRSDADVHAFVRAAVDRFGTVDVLVNNAGRSGGGVTADIADELWHDVIDTNLNSVFRLTREVLNTGGLRHKSWGRIINIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAQRVRQGYAAAYDTTEDAILEKFQSKIPLGRYSTPEEVAGLVGYLASDTAASITAQALNVCGGLGNF	MYVLSVEKPTLRNKFAAGIGVVLVCVVASFIPTPVFALDTTKLIQAVQSEESALHARVGMTVFDSNTGTTWNYRGDERFPLNSTHKTFSCAALLAKVDGKSLSLGQSVSISKEMLVTYSPITEKSLSPETVTFGKICQAAVSYSDNTAANVVFDAIGGATGFNAYMRSIGDEETQLDRKEPELNEGTPGDVRDTTTPNAMVNSLRKILLGDALSASSRSQLTQWMLDDQVAGALLRASLPSDWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGVVLKDTVAP	85.53	gnl|BL_ORD_ID|1061|hsp_num:0	1149			252	411	
BGC0000253.1|Oviedomycin_17 # 13516 # 14463 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.701	BGC0000253.1|Oviedomycin_17 	13516	14463	+	Loose	600	26.5646	OprZ	40.62	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCACCCGTGAGGTCGAGCACGAGATCACCATCGCCGCCCCGGCCGAGGCGGTGTACCGGCTGCTGGCCGACGTGGAGAACTGGCCGCGCATCTTCCCGCCCACCATCTTCGCCGACCGCCTGGAGGGCGGGGAGACCGAGGAGCGGATCCGGATCTGGGCCACCGCCAACGGCGAGGCCAAGAACTGGACGTCCCGCCGCACCCTGGAACCGCGGGGCCTTGTGATCACCTTCCGCCAGGAGGTGTCCGCCCCGCCGGTCGCGGCCATGGGCGGCACCTGGATCATCGAGCCGGCCGGCGAGTCCGCGGCCCGGGTGCGGCTGCTGCACGACTACCGCGCCGTCGACGACGACCCGGCCGGCCTGGCCTGGATCGACGAGGCCGTCGACCGCAACTCCCGCACCGAGCTGGCCTCGCTGAAGACCAACGTGGAGTTCGCGCACGCCGCGCGGGAGATCACCTTCTCCTTCGAGGACACCGTCCGCATCGACGGGTCGGCCAAGGACGTGTACGACTTCATCAACGACGCCCACCTGTGGTCCGAGCGGCTGCCGCACGTGGCCAGCGTGCGCTGCGAGGAGGAGTACCCGGGCCTGCAGACCCTGGAGATGGACACCCGGGCCAAGGACGGCTCGACCCACACCACCAAGTCGTACCGGGTCTGCTTCCCGCACCGGAAGATCGCCTACAAGCAGGTCACGCTGCCCGCGCTGATGAACCTGCACACCGGCTACTGGACCTTCACCGAGGACGCGGACGGGGTGTCGGCCTCCTCCCAGCACACCGTCGTCCTCAACACCGACAACATCACGCGGATCCTCGGCCCCGACGCCGGCATCCCCGAGGCCCGCGCCTACGTGCAGAGCGCGCTGAGCACCAACAGCCGCGCCACCCTCGGCCACGCCAAGGACTACGCCGAAGCACGGCGGAACCATGCGGACTGA	MTTREVEHEITIAAPAEAVYRLLADVENWPRIFPPTIFADRLEGGETEERIRIWATANGEAKNWTSRRTLEPRGLVITFRQEVSAPPVAAMGGTWIIEPAGESAARVRLLHDYRAVDDDPAGLAWIDEAVDRNSRTELASLKTNVEFAHAAREITFSFEDTVRIDGSAKDVYDFINDAHLWSERLPHVASVRCEEEYPGLQTLEMDTRAKDGSTHTTKSYRVCFPHRKIAYKQVTLPALMNLHTGYWTFTEDADGVSASSQHTVVLNTDNITRILGPDAGIPEARAYVQSALSTNSRATLGHAKDYAEARRNHAD	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	68.03	gnl|BL_ORD_ID|2408|hsp_num:0	2796			135	231	erythromycin; cefepime
BGC0000253.1|Oviedomycin_18 # 14453 # 15925 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.762	BGC0000253.1|Oviedomycin_18 	14453	15925	+	Loose	600	305.064	Streptomyces venezuelae rox	42.29	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCGGACTGACGTCCTCGTCGTCGGCGCGGGCCCGGTCGGGCTGATGCTCGCCGGTGAACTGCGCCTCGGCGGCGCCGAGGTGGTCGTGCTGGATCGGCTGCCCCGGCCCACCACCGAGTCCCGCGCGACGACCCTGCACGCCCGCACCATGGAGATCCTCGCCGCGCGCGGCCTGCTCGAGGCGCTCGGCACCCCGCCGAACGACGTGATGGGCCACTTCGGCGGCGTCCCGCTGGACCTCACCCTGCCCACGCCGTACCCCGGCCAGTGGAAGGTCCCGCAGACCCGCACCGAGGAACTGCTCCAGGCCTGGGCGCTCTCCCTCGGCGCCACCGTCCGCCGCGGCCACGAACTGCGCGCGCTGACCGTCACGGACACCGGTGCCGAGGCCGAGGCCACCGGCCCCGACGGCCGGCCCGTCCGGGTGAGCGCCCGCTACGTCGTCGGCTGCGACGGCGAGCGCAGCACCGTGCGCGAGCTGACCGGGGCCGACTTCCCCGGGCAGGACGCCACCCGCGAGCTGATCCGCGCCGACGTCGCCGGCATCGACATCCCCGACCGGCGCTTCCAGCGGCTCCAGCGGGGCCTGGCCATCGCCGCCCGCCGGCCCGACGGCGTCACCCGGGTGATGGTGCACGAGTTCGGCCGCGCGGCCCGGCCGCGCACCGGCGCCCCCGCCTTCGCCGAGGTCGTCGACGTGTGGAAGCGCGTGACCGGCGAGGACATCGGCGGCGGCACCCCGCTGTGGCTCAACGCCTTCGGTGACGCCTCCCGGCAGGTGGCGCGCTACCGCGACGGCCGCGTGCTGTTCGCCGGGGACGCCGCGCACGTCCAGATGCCCGTGGGCGGACAGGCCCTCAACCTCGGTCTCCAGGACGCGGTCAACCTCGGCTGGAAGCTCGCCGCCGAGATCCGGGGCCGGGCCCCGGACGGCCTGCTGGACACGTACCACTCCGAGCGGCACGCCGTCGGCGAGCGGGTGCTGAGCACCATCCGCGCCCAGTCGACGTTCCTGCTCGGCGGCCCGGACGTCGAGGCGCTGCGCGAGGTCTTCCGCGAGTTGATCGACCCCGCGCACACCCGTCACACCCGCGCCCACCTGGCCGGCCTGATCAGCGGCCTGGACATCCGGTACGACGTCGGCCCGGGCGACCATCCGCTGCTGGGCGCCCGTATGCCCTACGGCGAGCTGGACCAGGCCCCCGACGCGGCCTGCCGCAAGGCGCGCGGGGTGCTGCTGGACCTCGCGCCCGGCAGCCCGTCCGCGGCGGAGCTGCACGCCGTCGCCGCCGGCTGGGCGGACCGGGTGGACGTCGTCACGGCCGGGTTCCGTACCGCCGACGGACCTTCCGCTCTCTCGGGGGCGCGTGCCGTCCTGGTGCGGCCCGACGGCCACGTGGTCTGGACCGATTCCGGCGCGGGACGGCCGGAGACGGCCCTGCGCCGCTGGTTCGGCGCACCGGTGTCTTGA	MRTDVLVVGAGPVGLMLAGELRLGGAEVVVLDRLPRPTTESRATTLHARTMEILAARGLLEALGTPPNDVMGHFGGVPLDLTLPTPYPGQWKVPQTRTEELLQAWALSLGATVRRGHELRALTVTDTGAEAEATGPDGRPVRVSARYVVGCDGERSTVRELTGADFPGQDATRELIRADVAGIDIPDRRFQRLQRGLAIAARRPDGVTRVMVHEFGRAARPRTGAPAFAEVVDVWKRVTGEDIGGGTPLWLNAFGDASRQVARYRDGRVLFAGDAAHVQMPVGGQALNLGLQDAVNLGWKLAAEIRGRAPDGLLDTYHSERHAVGERVLSTIRAQSTFLLGGPDVEALREVFRELIDPAHTRHTRAHLAGLISGLDIRYDVGPGDHPLLGARMPYGELDQAPDAACRKARGVLLDLAPGSPSAAELHAVAAGWADRVDVVTAGFRTADGPSALSGARAVLVRPDGHVVWTDSGAGRPETALRRWFGAPVS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	102.94	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1416	rifampin; rifaximin; rifapentine
BGC0000253.1|Oviedomycin_19 # 15945 # 17465 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.747	BGC0000253.1|Oviedomycin_19 	15945	17465	+	Loose	600	265.774	Streptomyces venezuelae rox	40.64	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGTCGAAGTCCGCACCGCGGCCCCCGGCGGGCCCCCGCACGGCGACCGGCCCCGAGGTCCTGGTCGTCGGGGCGGGCCCCACCGGCCTGCTGCTGGCGGGAGACCTCGCCGCCGCCGGCACCCGGGTCACCGTCCTGGAGAAGCGCGGCCGGAAACTGAGCAACCTGACCCGCTCGTTCACCGTGCACGCGCGCACCCTGGAGCAGCTTCAGGCGCGCGGCGTCGCCGAGGACATCATCGCCACCGGCACCAAGCTGCCCACCCTGCCGCTCTTCGGCGACCTGGACATCCACTTCGCGCACCTGCGCACCCGCTACCCGTACGTGCTGATCACCCCGCAGTTTCACGTGGAACAAGTGCTGGAGCGACGGGCCGTCTCCCTCGGGGTGGAGTTCCGCCACGACACCGAGGTGACCGGGCTGCGCCAGGACGCGCACGGGGTCGAGCTGGACGCCGTCACCGCCGACGGCACCCGGGAGACCCACCGTGCGGCCTACGCGGTCGGCACCGACGGGGTGCGCAGCACCGTGCGGCGGCTGCTGGACATCCCCTTCCCCGGCGACTCCGTGCTGCGCTCGGTGATCCTCGCCGACGTGCTGATGAAGGAGGCGCCCGCCGACCTGCTCACCGTGGACGCCAACGAGCACGGGTTCGCCTTCGTCGCCCCCTTCGGCGACGGCTACTACCGCGTGCTCGCCTGGAACCGGCACACCGACAGCTCGGCGGACGAGTCCGTGGACTTCGAGGAGCTGCGCCGGCTGTGCCGGGCCATTCTCGGCCGGGACTTCGGCATGCACGAGCCGCGCTGGGTCTCGCGCTTCCACAGCGACGAGCGCCAGGCCACCCGGTACCGCGAGGGCCGCTTCTTCCTGGCCGGCGACGCCGCGCACGTCCACTCGCCGGCCGGCGGCATGGGCATGAACACCGGCCTGCAGGACGCGATGAACCTCGCCTGGAAGCTGGCGGCGGCGGTGCGCGGCCACGGCGACGACGCCCTGCTCGACACCTACGAGGCGGAGACCCATCCGGTCGGCGAGGAGGTGCTGCGCACCTCGGGCTCCCTGGTCCGCGCGGCCATCCGGCAGAGCGGACGCACCCGGCTCGCCCAGCAGGCGATGGTCTGGTTCGCCGGACACCTCGGCCCGCTCGGCGAGGCACTGGGCCGCCGGGAGGGCCTGGCCGTCTCCGGCACCGGTATCACCTACGGCCGGCAGCGCGGCGACCACCGGCTCGTCGGCCGGTTCTTCCACGGGCGGCTGACCGGCGGACGGCTCGACGGCGCCCTGGGCACCGGCCGGTTCGTGCTGCTCAGCCCCGACGAGGCCGTGCGCACGGCGGTGGCGGACTGGTCCGACCGCGTCGTGACCGCCCCCGCGGACGTCCGCACCACGCTGCTCATCCGGCCGGACGGGTACGTCGCCTGGGCGGCCGACGGCCCCGGCCCGGCGGCGGTCCGCGACGCCCTGAACCGCTGGGCGGGCCCGGCGGAACCCCGGATCCGGCTTGCGTACGCGGGCTGA	MSKSAPRPPAGPRTATGPEVLVVGAGPTGLLLAGDLAAAGTRVTVLEKRGRKLSNLTRSFTVHARTLEQLQARGVAEDIIATGTKLPTLPLFGDLDIHFAHLRTRYPYVLITPQFHVEQVLERRAVSLGVEFRHDTEVTGLRQDAHGVELDAVTADGTRETHRAAYAVGTDGVRSTVRRLLDIPFPGDSVLRSVILADVLMKEAPADLLTVDANEHGFAFVAPFGDGYYRVLAWNRHTDSSADESVDFEELRRLCRAILGRDFGMHEPRWVSRFHSDERQATRYREGRFFLAGDAAHVHSPAGGMGMNTGLQDAMNLAWKLAAAVRGHGDDALLDTYEAETHPVGEEVLRTSGSLVRAAIRQSGRTRLAQQAMVWFAGHLGPLGEALGRREGLAVSGTGITYGRQRGDHRLVGRFFHGRLTGGRLDGALGTGRFVLLSPDEAVRTAVADWSDRVVTAPADVRTTLLIRPDGYVAWAADGPGPAAVRDALNRWAGPAEPRIRLAYAG	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	106.30	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1371	rifampin; rifaximin; rifapentine
BGC0000253.1|Oviedomycin_21 # 18386 # 19930 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.709	BGC0000253.1|Oviedomycin_21 	18386	19930	+	Loose	1900	26.5646	MexK	48.15	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGGAAACAGCTTGACGAGCTGCTCGACATCAAGGAGTCGGCCCGGGGCGGCCCGGATCCGGACGCGACGCGCCGCCAGCACGACAAGGGCAAGCTCACCGCCCGCGAACGCATCGAGCTGCTGCTCGACAAGGACTCCTTCCAGGAGATCGAGCAGCTGCGCCGGCACCGCGCGACCGGCTTCGGCCTGGAGGCGAAGAAGCCGTACACCGACGGCGTGATCACCGGCTGGGGCACGGTCCACGGCCGGACCGTCTTCGTCTACGCGCACGACTTCCGCATCTTCGGCGGCGCGCTCGGCGAGGCCCACGCCCAGAAGATCCACAAGCTGATGGACATGGCGATCGCGGCCGGTGCGCCGCTGGTGTCGCTCAACGACGGCGCCGGCGCCCGCATCCAGGAGGGTGTCACCGCGCTCGCCGGCTACGGCGGCATCTTCCAGCGCAACACCCGCGCCTCCGGTGTCATCCCGCAGATCAGCGTCATGCTCGGCCCGTGCGCGGGCGGCGCCGCCTACAGCCCGGCGCTGACGGACTTCGTCTTCATGGTGCGCGGCACCTCGCAGATGTTCATCACCGGCCCCGACGTGGTCCGCGCGGTGACCGGCGAGGAGATCGGCCAGGAGGGGCTGGGCGGCGCGGACGTCCACTCCCGGACCTCGGGCGTCGCGCACTTCGCGTACGACGACGAGGAGACCTGCCTGGAGGAGGTCCGCTTCCTGCTGTCGATGCTGCCCGCCAACAACCGCGAGAGCGCCCCGGCCGTGCCCTGCGACGACCCGGCGGACCGGCGCGGCCAGGCCCTGTACGACCTGGTCCCGGCCGACGGCAACCGGCCGTACGACATGCGGGCCGTCATCGAGGAGATCGTCGACGACGGCACCCACCTGGAGGTCCACGAACGCTGGGCCACCAACGTCATCTGCACGCTGGCCCGCCTCGACGGCAAGGTGGTCGGCATCGTCGCCAACCAGCCGCAGTCCCTGGCGGGCGTGCTGGACATCGCCGCGTCCGAGAAGGCCGCGAGCTTCGTGCAGACCTGCGACTCCTTCAACATCCCCCTCGTGACCCTGCTGGACGTGCCCGGCTTCCTGCCCGGCGTGGACCAGGAGCACAACGGCATCATCCGGCACGGCGCCAAGCTGCTGTACGCGTACTGCAACGCGACCGTGCCCCGGATCTCCCTGGTGCTGCGCAAGGCGTACGGCGGCGCCTACATCGTCATGGACTCCCGCTCCATCGGCGCCGACCTGGCGCTGGCCTGGCCCACCAACGAGATCGCGGTGATGGGCGCCGAGGGCGCGGCGGGCGTCATCTTCCGGCGGGACATCAACGCCGCCGACGACCCCGAGGCCGTGCGCCGGCAGCGCGTCGAGGAGTACAAGGCCGAGCTGATGCACCCCTACTACGCCGCCGAACGCGGCCTGGTGGACGACGTGATCGACCCGGCCGACACCCGCGAGGTGCTGATCCGCGGCCTGGCGATGCTGCGCACCAAGCACGCCGACCTGCCGATGCGCAAGCACGGCAACCCGCCCCAGTGA	MRKQLDELLDIKESARGGPDPDATRRQHDKGKLTARERIELLLDKDSFQEIEQLRRHRATGFGLEAKKPYTDGVITGWGTVHGRTVFVYAHDFRIFGGALGEAHAQKIHKLMDMAIAAGAPLVSLNDGAGARIQEGVTALAGYGGIFQRNTRASGVIPQISVMLGPCAGGAAYSPALTDFVFMVRGTSQMFITGPDVVRAVTGEEIGQEGLGGADVHSRTSGVAHFAYDDEETCLEEVRFLLSMLPANNRESAPAVPCDDPADRRGQALYDLVPADGNRPYDMRAVIEEIVDDGTHLEVHERWATNVICTLARLDGKVVGIVANQPQSLAGVLDIAASEKAASFVQTCDSFNIPLVTLLDVPGFLPGVDQEHNGIIRHGAKLLYAYCNATVPRISLVLRKAYGGAYIVMDSRSIGADLALAWPTNEIAVMGAEGAAGVIFRRDINAADDPEAVRRQRVEEYKAELMHPYYAAERGLVDDVIDPADTREVLIRGLAMLRTKHADLPMRKHGNPPQ	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	50.15	gnl|BL_ORD_ID|2016|hsp_num:0	2206			1266	1347	erythromycin; tetracycline; triclosan
BGC0000253.1|Oviedomycin_22 # 19956 # 20165 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.748	BGC0000253.1|Oviedomycin_22 	19956	20165	+	Loose	3000	25.0238	abcA	35.14	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAGCACCACTGAGCCCCTCTTCCGGATCGTCCGGGGACAGGCCGACGCCGAGGAACTCGCCGCCCTGACGGCCGTACTGACCGTGCTCGCGCAGCGGGCGGGCGCCTCGGCGGAACCGGCCGCCCCGCGTCCGGCGGCCGCGCGCTGGTTCCGGCTGGAGCGCAACGCCGGATTCCTGGCCTCGCACAGCTGGCAGACCGCCTCGTAG	MSTTEPLFRIVRGQADAEELAALTAVLTVLAQRAGASAEPAAPRPAAARWFRLERNAGFLASHSWQTAS	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	4.75	gnl|BL_ORD_ID|2167|hsp_num:0	2416			1092	1203	methicillin; daptomycin; cefotaxime; moenomycin A1
BGC0000253.1|Oviedomycin_23 # 20498 # 22216 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.709	BGC0000253.1|Oviedomycin_23 	20498	22216	+	Loose	275	37.3502	vanE	24.45	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAGTCTGCGCAAGGTGCTCATCGCCAACCGTGGCGAAATCGCTGTCCGCGTGGCCCGGGCCTGCCGGGACGCCGGGATCGCGAGCGTGGCCGTCTACGCCGACCCGGACCGCGACGCTGTGCACGTACGGGCCGCCGACGAGGCGTTCGCGCTGGGGGGTGACACCCCGGCCACCAGCTACCTGGACATCGAGAAGGTGCTGCTGGCCGCCAAGCAGTCCGGTGCGGACGCGATCCACCCCGGCTACGGCTTCCTGTCCGAGAACGCCGAGTTCGCCCAGGCCGTTCTCGACGCGGGCCTGATCTGGATCGGCCCGCCGCCGCAGGCGATCCGGGACCTGGGTGACAAGGTCGCCGCCCGTCACATCGCCCAGCGCGCCGGCGCCCCGCTGGTGGCGGGTACGCCGGACCCGGTGAGTGGTGCGGAGGAGGTCGTGGCTTTCGCCGAGGAGCACGGTCTGCCGATCGCGATCAAGGCCGCGTTCGGCGGCGGCGGGCGCGGTCTGAAGGTCGCCCGCACCCTCGAAGAGGTCCCCGAGCTGTACGAGTCCGCCGTGCGTGAGGCCGTCGCCGCGTTCGGCCGTGGCGAGTGCTTCGTCGAGCGCTACCTCGACCGGCCGCGGCATGTGGAGACGCAGTGCCTGGCCGACAAGCACGGCAACGTCGTCGTGGTCTCCACCCGCGACTGCTCCCTGCAGCGCCGTCACCAGAAACTGGTCGAGGAGGCTCCCGCACCGTTCCTGTCCGAGGAGCAGATGGCGGAGCTGTACCGGGCGTCGAAGGCCATCCTGAAGGAGGCCGGGTACGAGGGCGCGGGCACGTGTGAGTTCCTGGTCGGGCAGGACGGCACGATCTCCTTCCTGGAGGTCAACACCCGCCTGCAGGTCGAGCACCCGGTCACCGAGGAAGTCGCCGGCATCGACCTGGTCCGGGAGATGTTCCGCATCGCCGACGGCGAACCCCTCGGCTACGACGACCCGGTGCTGCGCGGTCACTCCTTCGAGTTCCGTATCAACGGTGAGGACCCGGGCGTGCGTCTGGACGCGGGCGTGGAGGCCGGCAGTGTGATCGGCCCGGCGTGGGACTCCCTGCTGGCCAAGCTGATCGTCACCGGCCGCACCCGCAAGGAAGCCCTCCAGCGGGCCGCCCGCGCGCTGGAGGAGTTCCGTGTCGAGGGCATGGCCACCGCCATCCCCTTCCACCGCAAGGTCGTCACCGACCCCGCCTTCGCCCCCGAACTCACCGGCTCCAGCGAGCCGTTCACGGTCCACACCCGGTGGATCGAGACCGAGTTCGTCAACGACATCAAGCCCTTCACCGCCCCCGCCGACGCCGAGGCCGACGAGGATGCGGCGCGTGAGACGGTCGTGGTCGAGGTCGGCGGCAAGCGCCTGGAGGTCTCCCTGCCCTCCAGCCTGGGCATGAGCCTGGCCCGCACCGGGCTCGCGGCCGGGGCCAAGCCCAAGCGGCGCGCGGCGAAGAAGTCCGGGCCCGTCGCCTCCGGCGACACCCTGACCTCCCCCATGCAGGGCACCATCGTCAAGATCGCCGTCGAGGAAGGCCAGCAGGTCAAGGAGGGCGACCTGGTCGTCGTCCTGGAGGCCATGAAGATGGAACAGCCCCTCAACGCCCACAAGGCGGGCACCATCAAGGGCCTGACCGCCGAGGTCGGCGCCTCCCTCACCTCCGGCGCCGCCATCTGCGAGATCACGGACTGA	MSLRKVLIANRGEIAVRVARACRDAGIASVAVYADPDRDAVHVRAADEAFALGGDTPATSYLDIEKVLLAAKQSGADAIHPGYGFLSENAEFAQAVLDAGLIWIGPPPQAIRDLGDKVAARHIAQRAGAPLVAGTPDPVSGAEEVVAFAEEHGLPIAIKAAFGGGGRGLKVARTLEEVPELYESAVREAVAAFGRGECFVERYLDRPRHVETQCLADKHGNVVVVSTRDCSLQRRHQKLVEEAPAPFLSEEQMAELYRASKAILKEAGYEGAGTCEFLVGQDGTISFLEVNTRLQVEHPVTEEVAGIDLVREMFRIADGEPLGYDDPVLRGHSFEFRINGEDPGVRLDAGVEAGSVIGPAWDSLLAKLIVTGRTRKEALQRAARALEEFRVEGMATAIPFHRKVVTDPAFAPELTGSSEPFTVHTRWIETEFVNDIKPFTAPADAEADEDAARETVVVEVGGKRLEVSLPSSLGMSLARTGLAAGAKPKRRAAKKSGPVASGDTLTSPMQGTIVKIAVEEGQQVKEGDLVVVLEAMKMEQPLNAHKAGTIKGLTAEVGASLTSGAAICEITD	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	162.50	gnl|BL_ORD_ID|1478|hsp_num:0	1617			288	924	vancomycin
BGC0000253.1|Oviedomycin_24 # 22247 # 22765 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.692	BGC0000253.1|Oviedomycin_24 	22247	22765	-	Loose	210	38.1206	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	31.65	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGTGATCGCCAGCAAGCCGTCGATCGCGTCGACGTGATCATGAAGCAGGTCGCGCAGGTCTCGACGGCGCCCGACCTGACGTCCAAGGAACTCTGCCAGCGGATTCAGCGCGTCGCCCACCATCTGGAGACCCGGCTCCGCCGTGAACTGGCCGTCTTCGGCATCGAACCCTGGGAGATCGAGCTGCTCGCCTCCCTGCGCCGGGTCGGGCCGCCCCACCAGGTGACCGCCGGTTCGCTCCAGGACATCATGCAGCTGACCACCGGCGCCGTCACCAAGCGCGTGGCCGCCCTGGAGAAGAAGGGGTGGGTGCGCCGGGAGGTCGACGCCGGCGATCGCCGCCAGGTACTGGTCTGCCTCACGGACGAAGGGGAGCAGCGGGCGCTCGAGGTCTTCGCCACCAAGACGGAGACGGAGGCGCGGGTGCTGTCCGCCCTCGACCTCGACACCCAGCGGCGGCTCAACGACGATCTGCGCACGCTTCTGATCGACCTGGAGGGAGCGGTCCGCACCTGA	MGDRQQAVDRVDVIMKQVAQVSTAPDLTSKELCQRIQRVAHHLETRLRRELAVFGIEPWEIELLASLRRVGPPHQVTAGSLQDIMQLTTGAVTKRVAALEKKGWVRREVDAGDRRQVLVCLTDEGEQRALEVFATKTETEARVLSALDLDTQRRLNDDLRTLLIDLEGAVRT	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	119.44	gnl|BL_ORD_ID|1984|hsp_num:0	431			84	312	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000253.1|Oviedomycin_25 # 22849 # 23652 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.739	BGC0000253.1|Oviedomycin_25 	22849	23652	+	Loose	450	46.9802	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	34.0	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGACTCGTAGCGTCTCCGCATCCGGCCCGCTTCAGGGCAGGATCGCGCTGGTGACAGGCGGTAGCCGGGGGATCGGGGCCGCGACGGCCACCACCCTCGCCGGGCTCGGGGCCGACGTCGTGCTCACATACCGAAGCTCGCTGGACGAGGCCAAGGCCGTGGCGGCCGCGTGCGAGGAAAAAGGTGTAAAGGCCACGGTGCTCAGGGCCGACCTGGACGCGGCCGACGGCGCCGAGGAACTGGTCACCGCCGTGCGGGAACGGGTGGACCACCTCGACGTCGTCGTCAGCAACGCCTGCGCCTCGTACCCGCGCGTGCCGCTGGCCGGCATGGACCCGACCGCGCTCGGCGACAAGGTCCGCAACGACGTCGTCCTGCTGCACCGGCTCACCACCGCCTTCGTGCCCGCGATGCGGGAGCGGGGGTACGGCCGGCTCGTCGTCATCTCCAGCGGCTCGTCCTGGGGCCCGACCGCGCCCGGCCTCGCCGCGCACGGAGTGACGAAGGCCGCGCTGGAGGGCTACGTCCGGTACGCGGCCGACGAGTTCGGCGCCGGTGGCGTGACCGTCAACGGCCTCGCCCTGGGCTTCGTCCTCACCGACGCCTCCTCGGTGGTCCCGCAGCCGGCGCGCGACGCGCTGGCCAACGCCACGCCGGCCGGGCGGCTCGGCACCCCGCAGGACATCGCCGACGCCGTGTCCCTGCTGGCGCGCCCCGAGTCGGAGTGGATCAACGGGGCGACCCTCCCCGTGACCGGCGGCCTCAACTACCCGCTGAACCTGTCCCGCGTCCGCGGCCACTGA	MTRSVSASGPLQGRIALVTGGSRGIGAATATTLAGLGADVVLTYRSSLDEAKAVAAACEEKGVKATVLRADLDAADGAEELVTAVRERVDHLDVVVSNACASYPRVPLAGMDPTALGDKVRNDVVLLHRLTTAFVPAMRERGYGRLVVISSGSSWGPTAPGLAAHGVTKAALEGYVRYAADEFGAGGVTVNGLALGFVLTDASSVVPQPARDALANATPAGRLGTPQDIADAVSLLARPESEWINGATLPVTGGLNYPLNLSRVRGH	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	101.91	gnl|BL_ORD_ID|4712|hsp_num:0	2666			459	756	triclosan
BGC0000253.1|Oviedomycin_26 # 23903 # 24418 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	BGC0000253.1|Oviedomycin_26 	23903	24418	+	Loose	275	25.409	Streptomyces rimosus otr(A)	37.25	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCAGCGATCCTCCTCAGAAGCCGCGGCGCAGGCCGTGCCCCCCACCTCCGACTCGGGCGGATCCGGTCCCCGGGACTTACGGCGTCCCGGCCCGGCCGGTGACCGGCCACCCGCCCGCTGGGCGCACCGGCCGGTGATCGCCTTCCGGATCGTCTCCGTGCTGTTCACCGTCAACACCCTCGTCCAGGCCGCGCTGGCCGGGCTGTTCGTCAACGGCGACGTGGGACTGCTCACCGCCCACGACGTCAACGCGCACGTTCTCACGATGATGCTCGTGGCGGAGACGGCAGCCGCCACCGTCGCCTGGAGGGCGCGCGCGAACCGGGTCTGGCCCACGGTCCTCGGCGCCGCCCTCCTCGTGCTGATCGTCGTTCAGCAGATCGCCGGGTACTCGCGGAACCTGCTGCTGCACATCCCGCTCGGTGTCGCCCTGTTCGGCGGCGCGTGCACGATGACGGTCTGGGCGTTCACCCTCACCCTGCCCGTCCGGACGCTCAAGGCGCTGCACCGATGA	MQRSSSEAAAQAVPPTSDSGGSGPRDLRRPGPAGDRPPARWAHRPVIAFRIVSVLFTVNTLVQAALAGLFVNGDVGLLTAHDVNAHVLTMMLVAETAAATVAWRARANRVWPTVLGAALLVLIVVQQIAGYSRNLLLHIPLGVALFGGACTMTVWAFTLTLPVRTLKALHR	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	25.79	gnl|BL_ORD_ID|4807|hsp_num:0	1273			555	696	oxytetracycline
